Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says AnalystBenzinga • 10/25/24
ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins ExpandZacks Investment Research • 10/25/24
ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 10/24/24
ResMed beats quarterly profit estimates on strong demand for its sleep apnea devicesReuters • 10/24/24
ResMed Adds To Its Recent Sprint, Shrugging Off Worries Tied To Obesity DrugsInvestors Business Daily • 10/24/24
Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 10/21/24
RMD Stock Likely to Gain From Enhanced Digital Sleep Health SolutionsZacks Investment Research • 10/01/24
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder ReturnsGlobeNewsWire • 09/30/24
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep HealthGlobeNewsWire • 09/30/24
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep HealthGlobeNewsWire • 09/30/24
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep HealthGlobeNewsWire • 09/30/24
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep HealthGlobeNewsWire • 09/30/24
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of SafetySeeking Alpha • 09/19/24